Professor Didier Raoult Publishes Results of a Hydroxychloroquine Treatment Study on 1061 Patients

0
2038

by Arjun Walia, Collective Evolution:

  • The Facts:Professor Didier Raoult has been published his early results for Hydroxychloroquine as a treatment for moderate to severe COVID-19 patients. 973 patients out of 1063, according to him, have shown “a good clinical outcome.”
  • Reflect On:Why is there always so much controversy and politicization of science and treatments? Why are these treatments controversial within the mainstream, but vaccines cannot even be questioned?

In a new study performed at IHU Méditerranée Infection, Marseille, France a  cohort of 1061 COVID-19 patients were treated for 3 days with the Hydroxychloroquine-Azithromycin (HCQ-AZ) combination. A follow-up of at least 9 days was investigated and the study found that no cardiac toxicity was observed. According to the abstract which was recently released:

“A good clinical outcome and virological cure was obtained in 973 (out of 1061) patients within 10 days (91.7%)…A poor outcome was observed for 46 patients (4.3 %); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization or more…The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.” 

The original abstract can be accessed here.

Also, the researchers made this table available.

I came across this information via the Physicians For Informed Consent

It’s not clear when the complete study will be made available. But there is another side to this story, Sciencemg  points out that:

The popular faith in hydroxychloroquine stands in stark contrast to the weakness of the data. Several studies of its efficacy against COVID-19 have delivered an equivocal or negative verdict, and it can have significant side effects, including heart arrhythmias. Raoult’s positive studies have been widely criticized for their limitations and methodological issues. The first included only 42 patients, and Raoult chose who received the drug or a placebo, a no-no in clinical research; the International Society of Antimicrobial Chemotherapy has distanced itself from the paper, published in the society’s International Journal of Antimicrobial Agents. The second study, published as a preprint without peer review, didn’t have a control group at all.

They go on to mention that:

Raoult has dismissed the criticism and complained about the “dictatorship of the methodologists” who insist on randomization and control groups in clinical trials. In his hospital, every patient diagnosed with COVID-19 receives hydroxychloroquine combined with azithromycin, an antibiotic. Raoult claims this has resulted in a very low death rate, which he says he will document soon in a publication.

Raoult has also found some high-level support in the medical world. An online petition in support of hydroxychloroquine was started by cardiologist and former Minister of Health Philippe Douste-Blazy—France’s candidate to lead the World Health Organization in 2017—and Christian Perronne, head of infectious diseases at the renowned Raymond Poincaré University Hospital in Garches, near Paris. Ten other prominent figures from the medical community, including two members of the Academy of Medicine, have also co-signed the petition, which demands hydroxychloroquine be authorized in hospital settings.

This has become a highly controversial topic that’s been politicized, as with most other medications and drugs. Profit and corporate interests are at stake, and therefore mass perceptions of it are controlled using various tactics and media. Sometimes it can be hard to decipher truth.

These findings also correlate with others that have been gaining attention as well.

For example, Dr. Vladimir Zelenko, a board-certified family practitioner in New York, said in a video interview that a cocktail of Hydroxychloroquine, Zinc Sulfate and Azithromycin are showing phenomenon results with 900 coronavirus patients treated. (source)

In that video he stated that he believes it’s very important to “get this information out to the American people and to the world.”

Dr. Anthony Cardillo, an ER specialist and the CEO of Mend Urgent Care, has been prescribing the zinc and hydroxychloroquine combination on patients experiencing severe symptoms associated with COVID-19. In an interview with KABC-TV, Cardillo stated:

“Every patient I’ve prescribed it to has been very, very ill and within 8 to 12 hours, they were basically symptom-free, […] So, clinically I am seeing a resolution.”

“We have to be cautious and mindful that we don’t prescribe it for patients who have COVID who are well,” he said. “It should be reserved for people who are really sick, in the hospital or at home very sick, who need that medication. Otherwise we’re going to blow through our supply for patients that take it regularly for other disease processes.”

According to Cardillo, it’s the combination of zinc and hydroxychloroquine that does the job. “[Hydrocychloroquine] opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.”

President Donald Trump has also been quite outspoken about this treatment in some of his recent press conference. We’ve seen many mainstream media publications, however, downplay the potential of this treatment which may be confusing people.

Read More @ Collective-Evolution.com